Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01191580 · ClinicalTrials.gov registry record · Phase 4
Interpersonal Therapy for Depression in Breast Cancer
A Phase 4 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 134
- Enrollment target
NCT01191580: Completed Phase 4 study, sponsored by New York State Psychiatric Institute.
NCT01191580 is a Phase 4 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 134 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01191580, a Phase 4 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 134 participants
- Enrollment target
Study Summary
The investigators propose a randomized clinical trial to compare the efficacy of Interpersonal Psychotherapy (IPT), Problem-Solving Therapy (PST), and Brief Supportive Psychotherapy (BSP), in improving depressive symptoms, psychosocial functioning, and quality of life among patients with breast cancer and major depressive disorder (MDD).
Primary Outcome
Change in HAMD-17 following acute treatment is the primary outcome measure
Interventions
- BEHAVIORAL Interpersonal Psychotherapy
- BEHAVIORAL Brief Supportive Psychotherapy
- BEHAVIORAL Problem-Solving Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2009-10 |
| Est. Completion | 2017-06 |
| Phase | Phase 4 |
What the finished NCT01191580 record still lists
NCT01191580 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 3 interventions - of which Interpersonal Psychotherapy is the first listed.
NCT01191580 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01191580 about?
NCT01191580 is a clinical study titled "Interpersonal Therapy for Depression in Breast Cancer". The investigators propose a randomized clinical trial to compare the efficacy of Interpersonal Psychotherapy (IPT), Problem-Solving Therapy (PST), and Brief Supportive Psychotherapy (BSP), in improving depressive symptoms, psychosocial functioning, and quality of life among patients with breast canc...
What is the current status of trial NCT01191580?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 134 participants. The study started on 2009-10. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01191580?
The interventions under investigation include: Interpersonal Psychotherapy (BEHAVIORAL), Brief Supportive Psychotherapy (BEHAVIORAL), Problem-Solving Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01191580?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01191580's enrollment target sits among peer trials
134 606th of 2000 higher than 1,391 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia